Ikaria, NuPathe File Initial Public Offerings
Weak performance by a smattering of biotechs that went public in early 2010 hasn't deterred two more from being first to register this year.
Weak performance by a smattering of biotechs that went public in early 2010 hasn't deterred two more from being first to register this year.